Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis

被引:4
|
作者
Ginard, Daniel [1 ]
Marin-Jimenez, Ignacio [2 ]
Barreiro-de Acosta, Manuel [3 ]
Ricart, Elena [4 ,5 ]
Domenech, Eugeni [5 ,6 ]
Gisbert, Javier P. [5 ,7 ]
Esteve, Maria [5 ,8 ]
Minguez, Miguel [9 ]
机构
[1] Hosp Univ Son Espases, Serv Aparato Digest, Palma De Mallorca, Spain
[2] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Serv Med Aparato Digest, Madrid, Spain
[3] Hosp Univ Santiago de Compostela, Serv Aparato Digest, Santiago De Compostela, A Coruna, Spain
[4] Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAP, Serv Gastroenterol, Barcelona, Spain
[5] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
[6] Hosp Badalona Germans Trias & Pujol, Serv Aparato Digest, Barcelona, Spain
[7] Univ Autonoma Madrid, Hosp Univ Princesa, Inst Invest Sanitaria Hosp La Princesa IIS IP, Serv Aparato Digest, Madrid, Spain
[8] Hosp Univ Mutua Terrassa, Serv Aparato Digest, Barcelona, Spain
[9] Univ Valencia, Hosp Clin Valencia, Serv Med Digest, Valencia, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2020年 / 43卷 / 02期
关键词
Topical treatment; Ulcerative colitis; Mesalazine; Corticosteroids; 5-AMINOSALICYLIC ACID; DOUBLE-BLIND; CLINICAL-TRIAL; RECTAL MESALAMINE; MESALAZINE ENEMAS; EFFICACY; PROCTITIS; COMBINATION; FOAM; SUPPOSITORIES;
D O I
10.1016/j.gastrohep.2019.10.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although most patients with ulcerative colitis should be given topical treatment, different studies have shown that they are underused in clinical practice. The purpose of this article is to answer 10 specific questions about which drugs are available for topical use in the treatment of ulcerative colitis, and their characteristics in terms of formulation, dosage, presentation, application and proximal distribution of rectal-administered drugs. The efficacy of available topical drugs and the benefits of combining different formulations and routes of administration, and their usefulness during disease remission are evaluated. Finally, a series of recommendations addressed to patients are given on the correct application of topical treatment. (C) 2019 The Authors. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 50 条
  • [11] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease
    Domenech, Eugeni
    Lopez-Sanroman, Antonio
    Nos, Pilar
    Vera, Maribel
    Chaparro, Maria
    Esteve, Maria
    Gisbert, Javier R.
    Manosa, Miriam
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (07): : 472 - 483
  • [12] Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease
    Gomolion, Fernando
    Rubio, Saioa
    Charro, Mara
    Garcia-Lopez, Santiago
    Munoz, Fernando
    Gisbert, Javier P.
    Domenech, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (01): : 24 - 30
  • [13] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease
    Riestra, Sabino
    Taxonera, Carlos
    Zabana, Yamile
    Carpio, Daniel
    Beltran, Belen
    Manosa, Miriam
    Gutierrez, Ana
    Barreiro-de Acosta, Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (01): : 51 - 66
  • [14] Recommendations of the Spanish Working Group on Crohn's disease and Ulcerative Colitis (Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa - GETECCU) on dysplasia screening in inflammatory bowel disease patients
    Sicilia, Beatriz
    Vicente, Raquel
    Arias, Lara
    Echarri, Ana
    Zabana, Yamile
    Manosa, Miriam
    Beltran, Belen
    Barreiro-de Acosta, Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (06): : 435 - 447
  • [15] Ulcerative duodenitis with ulcerative colitis - Is it Crohn's Disease or really ulcerative colitis?
    Korelitz, BI
    Rajapakse, R
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (02) : 97 - 97
  • [16] Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) survey on the management of patients with inflammatory bowel disease
    Ginard, Daniel
    Ricote, Mercedes
    Nos, Pilar
    Pejenaute, M. Elena
    Sans, Miquel
    Fontanillas, Noelia
    Acosta, Manuel Barreiro-de
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (08): : 647 - 656
  • [17] Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease
    Moya, Marta Calvo
    Gismero, Francisco Mesonero
    Ferrer, Cristina Suarez
    Hernandez-Camba, Alejandro
    Carlon, Danizar Vasquez
    Benasach, Fatima Garcia
    Peris, Mariam Aguas
    Oliva, Francisco Jose Delgado
    Gonzalez-Lama, Yago
    Scheiding, Monica Millan
    Sebastian, Isabel Alonso
    Martel, Laura Camacho
    Arriero, Vanesa Gallardo
    Piudo, Ana Echarri
    Castillo, Pablo Bella
    Sanz, Noelia Cano
    Mendoza, Maria Isabel Vera
    Labajos, Ruth Serrano
    Martinez, Antonio Valdivia
    Restoy, Lourdes Perez
    Abdo, Yamile Zabana
    Ciria, Miriam Manosa
    Rodriguez-Moranta, Francisco
    Barreiro-de Acosta, Manuel
    Casbas, Ana Gutierrez
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (07): : 774 - 792
  • [18] Surgical therapy for ulcerative colitis and Crohn's disease
    Becker, JM
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1999, 28 (02) : 371 - +
  • [19] Differential therapy of ulcerative colitis and Crohn's disease
    Stange, EF
    LEBER MAGEN DARM, 1999, 29 (05) : 221 - 226
  • [20] Immunosuppression therapy in ulcerative colitis and Crohn's disease
    Present, DH
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 218 - 226